Foot-and-Mouth Disease Virus Lacking the Leader Protein and Containing Two Negative DIVA Markers (FMDV LL3B3D A<sub>24</sub>) Is Highly Attenuated in Pigs
Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recomb...
Main Authors: | Michael Eschbaumer, Veronika Dill, Jolene C. Carlson, Jonathan Arzt, Carolina Stenfeldt, Peter W. Krug, John M. Hardham, Jacob E. Stegner, Luis L. Rodriguez, Elizabeth Rieder |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
MDPI AG
2020-02-01
|
Colecção: | Pathogens |
Assuntos: | |
Acesso em linha: | https://www.mdpi.com/2076-0817/9/2/129 |
Registos relacionados
-
Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency
Por: John M. Hardham, et al.
Publicado em: (2020-09-01) -
Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR
Por: Muneeswaran Selvaraj, et al.
Publicado em: (2021-11-01) -
The Safety and Efficacy of New DIVA Inactivated Vaccines Against Lumpy Skin Disease in Calves
Por: Gaetano Federico Ronchi, et al.
Publicado em: (2024-11-01) -
Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
Por: Tinka Jelsma, et al.
Publicado em: (2021-05-01) -
Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins
Por: Anne Balkema-Buschmann, et al.
Publicado em: (2022-05-01)